Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent

Onuma, Yoshinobu; Honda, Yasuhiro; Asano, Taku; Shiomi, Hiroki; Kozuma, Ken; Namiki, Atsuo; Yasuda, Satoshi; Ueno, Takayoshi; Ando, Kenji; Furuya, Jungo; Hanaoka, Keiichi Igarashi; Tanabe, Kengo; Okada, Kozo; Kitahara, Hideki; Ono, Masafumi; Kusano, Hajime; Rapoza, Richard; Simonton, Charles A.; Popma, Jeffrey J.; Stone, Gregg W.; Fitzgerald, Peter J.; Serruys, Patrick W.; Kimura, Takeshi

doi:10.1016/j.jcin.2019.09.047

Cited by 19 publications

(7 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Serruys et al demonstrated that BRS implantation was associated with a higher incidence of expansive remodeling and late lumen enlargement at 3 years compared to metallic stents in the ABSORB II trial ( 51 ). Although this favorable effect was not consistent in other ABSORB trials ( 78 ), it will be important to assess remodeling patterns at long-term follow-up after the full absorption of the deployed scaffolds.…”

Section: Introductionmentioning

confidence: 83%

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

Ono

Kawashima

Hara

et al. 2020

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have been developed and improved as both diagnostic and guidance tools for interventional procedures over the past three decades. IVUS has a resolution of 100 µm with a high tissue penetration and capability of assessing the entire structure of a coronary artery including the external elastic membrane, whereas OCT has a higher resolution of 10-20 µm to assess endoluminal structures with a limited tissue penetration compared to IVUS. Recently, two companies, CONAVI and TERUMO, integrated IVUS and OCT into a single catheter system. With their inherent strength and limitations, the combined IVUS and OCT probes are complementary and work synergistically to enable a comprehensive depiction of coronary artery. In this review, we summarize the performance of the two intracoronary imaging modalities-IVUS and OCT-and discuss the expected potential of the novel hybrid IVUS-OCT catheter system in the clinical field.

show abstract

Section: Introductionmentioning

confidence: 83%

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

Ono

Kawashima

Hara

et al. 2020

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

show abstract

“…In addition, intraluminal dismantling of the Absorb BVS at sites without complete endothelialisation during the resorption process has been suggested as a new mechanism of DT 19 . Well-apposed and embedded struts at baseline can still protrude into the lumen later on during the reabsorption process 20 . It is also plausible that good apposition at baseline would not prevent the occurrence of acquired malapposition, as large plaque burden continues to exert an inner force on the progressively weaker resorbing device.…”

Section: Effect Of Daptmentioning

confidence: 99%

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial

Kerkmeijer¹,

Renkens²,

Tijssen³

et al. 2022

EuroIntervention

View full text Add to dashboard Cite

show abstract

“…Consistently, with the extension of follow-up time, the risk of VLScT was gradually increased ( 48 ). The 3 year follow-up of the ABSORB Japan trial showed that intraluminal scaffold dismantling was suspected to have a causal relationship with VLScT ( 49 ). In addition, data from 38 cases of VLScT in 36 patients showed scaffold discontinuity in 42.1% of cases using OCT imaging ( 50 ).…”

Section: Scaffold Thrombosismentioning

confidence: 99%

Bioresorbable Scaffolds: Contemporary Status and Future Directions

Xiang

Jia

et al. 2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Percutaneous coronary intervention, which is safe, effective, and timely, has become an important treatment for coronary artery diseases and has been widely used in clinical practice. However, there are still some problems that urgently need to be solved. Permanent vessel caging through metallic implants not only prevents the process of positive vessel remodeling and the restoration of vascular physiology but also makes the future revascularization of target vessels more difficult. Bioresorbable scaffolds (BRSs) have been developed as a potential solution to avoid the above adverse reactions caused by permanent metallic devices. BRSs provide temporary support to the vessel wall in the short term and then gradually degrade over time to restore the natural state of coronary arteries. Nonetheless, long-term follow-up of large-scale trials has drawn considerable attention to the safety of BRSs, and the significantly increased risk of late scaffold thrombosis (ScT) limits its clinical application. In this review, we summarize the current status and clinical experiences of BRSs to understand the application prospects and limitations of these devices. In addition, we focus on ScT after implantation, as it is currently the primary drawback of BRS. We also analyze the causes of ScT and discuss improvements required to overcome this serious drawback and to move the field forward.

show abstract

Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent

Cited by 19 publications

References 25 publications

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial

Bioresorbable Scaffolds: Contemporary Status and Future Directions

Contact Info

Product

Resources

About